RIM
REGN icon

Rainier Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Rainier Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,700
Closed -$1.65M – 115
2017
Q3 		$1.65M Sell
3,700
-1,180
-24% -$561K 0.39% 104
2017
Q2 		$2.4M Sell
4,880
-3,940
-45% -$1.72M 0.48% 99
2017
Q1 		$3.42M Buy
8,820
+4,760
+117% +$1.76M 0.37% 114
2016
Q4 		$1.49M Buy
+4,060
New +$1.54M 0.15% 144
2016
Q1 		– Sell
-30,337
Closed -$16.5M – 205
2015
Q4 		$16.5M Sell
30,337
-4,850
-14% -$2.63M 0.64% 62
2015
Q3 		$16.4M Sell
35,187
-8,385
-19% -$4.5M 0.6% 69
2015
Q2 		$22.2M Sell
43,572
-74,320
-63% -$36.3M 0.7% 44
2015
Q1 		$53.2M Buy
117,892
+27,585
+31% +$11.7M 1.07% 20
2014
Q4 		$37M Sell
90,307
-49,090
-35% -$19.3M 0.66% 53
2014
Q3 		$50.3M Sell
139,397
-4,556
-3% -$1.53M 0.84% 34
2014
Q2 		$40.7M Sell
143,953
-37,557
-21% -$11.1M 0.63% 59
2014
Q1 		$54.5M Sell
181,510
-64,360
-26% -$19.8M 0.65% 52
2013
Q4 		$67.7M Sell
245,870
-38,200
-13% -$11M 0.7% 51
2013
Q3 		$88.9M Buy
284,070
+104,660
+58% +$27.5M 0.86% 38
2013
Q2 		$40.3M Buy
+179,410
New +$41.8M 0.37% 101

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Rainier Investment Management's REGN Position: Q4 2017 in Review

Rainier Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2017, closing a stake of 3,700 shares — an estimated $1.65M sold.

Rainier Investment Management first reported a position in REGN in Q2 2013 and held it in 15 quarters. The position peaked at $88.9M in Q3 2013. 639 funds tracked by Wall St. Rank hold REGN as of Q4 2017.

  • Rainier Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Rainier Investment Management sold 3,700 Regeneron Pharmaceuticals shares in Q4 2017, an estimated $1.65M.
  • Rainier Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Rainier Investment Management's Regeneron Pharmaceuticals position peaked at $88.9M in Q3 2013.
  • 639 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2017.

Based on Rainier Investment Management's 13F filing for Q4 2017, filed 2 Feb 2018.